Omega Healthcare Investors (NYSE:OHI) Upgraded to Outperform at BNP Paribas

Omega Healthcare Investors (NYSE:OHI) was upgraded by analysts at BNP Paribas from a “neutral” rating to an “outperform” rating in a report issued on Thursday, FinViz reports. The firm presently has a $49.00 price objective on the real estate investment trust’s stock. BNP Paribas’ price objective would indicate a potential upside of 15.13% from the stock’s current price.

Several other research firms have also issued reports on OHI. Scotiabank lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a report on Wednesday, September 4th. Mizuho lowered shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their target price for the company from $34.00 to $35.00 in a report on Thursday, July 25th. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 target price for the company. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $39.70.

Omega Healthcare Investors Stock Performance

Omega Healthcare Investors stock opened at $42.56 on Thursday. The stock’s 50 day simple moving average is $40.34 and its two-hundred day simple moving average is $35.84. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The stock has a market cap of $10.97 billion, a price-to-earnings ratio of 32.49, a PEG ratio of 1.34 and a beta of 1.00. Omega Healthcare Investors has a fifty-two week low of $27.53 and a fifty-two week high of $42.67.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The business had revenue of $252.70 million for the quarter, compared to analysts’ expectations of $205.92 million. During the same quarter in the previous year, the business posted $0.74 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 17.5% on a year-over-year basis. As a group, analysts expect that Omega Healthcare Investors will post 2.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company’s stock, valued at $4,025,000. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of OHI. Daiwa Securities Group Inc. boosted its holdings in Omega Healthcare Investors by 1,030.8% in the 2nd quarter. Daiwa Securities Group Inc. now owns 945,523 shares of the real estate investment trust’s stock worth $32,384,000 after buying an additional 861,907 shares during the period. Marshall Wace LLP bought a new position in Omega Healthcare Investors in the 2nd quarter worth $20,962,000. BROOKFIELD Corp ON bought a new position in Omega Healthcare Investors in the 1st quarter worth $16,446,000. Dimensional Fund Advisors LP boosted its holdings in Omega Healthcare Investors by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust’s stock worth $127,831,000 after buying an additional 272,299 shares during the period. Finally, Sei Investments Co. boosted its holdings in Omega Healthcare Investors by 150.8% in the 2nd quarter. Sei Investments Co. now owns 298,761 shares of the real estate investment trust’s stock worth $10,233,000 after buying an additional 179,623 shares during the period. Institutional investors own 65.25% of the company’s stock.

About Omega Healthcare Investors

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.